Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Confirmatory Study of OPC-12759 Ophthalmic Suspension in Dry Eye Patients
jRCT2080220723Phase 3
- Sponsor
- Otsuka Holdings
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of rebamipide in dry eye syndrome (DED) (2 arms), sponsored by Otsuka Holdings.
02
Drugs
rebamipide
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on jRCT2080220723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220723.